Tagged Articles

generic Reglan 2 articles

NJ Supreme Court allows state lawsuits against makers of generic Reglan to proceed

The New Jersey Supreme Court unanimously upheld a lower court’s 2014 ruling that consumers with state law claims blaming the manufacturers of generic versions of the heartburn drug Reglan for not adequately warning about neurological side effects, are not preempted by federal law. The lawsuits claim that generics manufacturers, including Pliva Inc., Actavis Elizabeth LLC, and Teva Pharmaceuticals USA Inc., delayed changing the labels of generic Reglan, known chemically as metoclopramide so that it conformed with the brand-name version of the drug. The New Jersey Supreme Court said that by not changing the labels to match that of the brand-name drug, the ... Read More

Supreme Court denies Teva’s appeal on generic Reglan failure-to-warm ruling

The U.S. Supreme Court rejected Teva Pharmaceuticals’ request to appeal a 2013 Pennsylvania Superior Court decision and subsequent denial of an appeal claiming that federal law preempted the product liability claims of about 2,300 generic Reglan users. The claims involving generic versions of the acid reflux drug Reglan, which contains the active ingredient metoclopramide, allege that long-term use of the medication can cause a serious neurological disorder known as tardive dyskinesia. However, plaintiffs argued that nearly 30 percent of generic drug makers failed to warn consumers of the devastating Reglan side effect. In December, Teva and Morton Grove Pharamceuticals Inc., ... Read More